DK0840615T3 - Kemokin-bindende protein og fremgangsmåder til anvendelse deraf - Google Patents

Kemokin-bindende protein og fremgangsmåder til anvendelse deraf

Info

Publication number
DK0840615T3
DK0840615T3 DK96921023T DK96921023T DK0840615T3 DK 0840615 T3 DK0840615 T3 DK 0840615T3 DK 96921023 T DK96921023 T DK 96921023T DK 96921023 T DK96921023 T DK 96921023T DK 0840615 T3 DK0840615 T3 DK 0840615T3
Authority
DK
Denmark
Prior art keywords
binding protein
chemokine
methods
poxviruses
interferon
Prior art date
Application number
DK96921023T
Other languages
English (en)
Inventor
Grant Mcfadden
Alexandra Lucas
Original Assignee
Robarts John P Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robarts John P Res Inst filed Critical Robarts John P Res Inst
Application granted granted Critical
Publication of DK0840615T3 publication Critical patent/DK0840615T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK96921023T 1995-04-19 1996-04-19 Kemokin-bindende protein og fremgangsmåder til anvendelse deraf DK0840615T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42485095A 1995-04-19 1995-04-19
PCT/IB1996/000680 WO1996033730A2 (en) 1995-04-19 1996-04-19 Chemokine binding protein and methods of use therefor

Publications (1)

Publication Number Publication Date
DK0840615T3 true DK0840615T3 (da) 2003-08-18

Family

ID=23684134

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96921023T DK0840615T3 (da) 1995-04-19 1996-04-19 Kemokin-bindende protein og fremgangsmåder til anvendelse deraf

Country Status (11)

Country Link
US (1) US5834419A (da)
EP (1) EP0840615B1 (da)
JP (2) JP4077876B2 (da)
AT (1) ATE243526T1 (da)
AU (1) AU718049B2 (da)
CA (1) CA2218499C (da)
DE (1) DE69628838T2 (da)
DK (1) DK0840615T3 (da)
ES (1) ES2202452T3 (da)
PT (1) PT840615E (da)
WO (1) WO1996033730A2 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495515B1 (en) * 1995-04-19 2002-12-17 Viron Therapeutics, Inc. Chemokine binding protein and methods of use therefor
ATE196091T1 (de) * 1996-05-22 2000-09-15 Univ Alberta Typ-2 chemokine-bindende proteine und verfahren zu deren verwendung
EP1034789A1 (en) * 1996-05-22 2000-09-13 University Of Alberta Type-2 chemokine binding proteins and methods of use therefor
EP0985046B1 (en) 1997-02-21 2006-04-12 Oxxon Therapeutics Limited Recombinant poxvirus incapable of expressing a41l gene, coding for a soluble protein that binds chemokines
AU2218999A (en) * 1998-01-09 1999-07-26 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Broad spectrum chemokine antagonist and uses thereof
US6869606B1 (en) 1999-02-22 2005-03-22 Millennium Pharmaceuticals, Inc. Biotinylated-chemokine antibody complexes
US6589933B1 (en) 1999-04-02 2003-07-08 Viron Therapeutics, Inc. Myxoma chemokine binding protein
EP1200595A2 (en) * 1999-07-12 2002-05-02 Viron Therapeutics, Inc. Myxoma virus genes for immune modulation
AU2001261738A1 (en) * 2000-05-17 2001-11-26 London Health Sciences Centre Compositions and methods for promoting immunosuppression
AU2002211744B8 (en) 2000-10-11 2008-03-20 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
CA2428097A1 (en) * 2000-12-04 2002-06-13 Viron Therapeutics, Inc. Immunomodulatory protein derived from the yaba monkey tumor virus
US20040241163A1 (en) * 2001-04-05 2004-12-02 Thomas Shenk Compositions and methods for treating inflammation and related conditions
US20020165161A1 (en) * 2001-05-04 2002-11-07 Surromed, Inc. Chemokine-binding proteins for treating congestive heart failure
AU2002368225A1 (en) * 2001-10-10 2004-05-04 Mount Sinai School Of Medicine Of The City University Of New York Viral interferon antagonists and uses therefor
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
US20030161937A1 (en) * 2002-02-25 2003-08-28 Leiby Mark W. Process for coating three-dimensional substrates with thin organic films and products
WO2003092615A2 (en) * 2002-05-01 2003-11-13 Beth Israel Deaconess Medical Center Use of anti-cd1 antibodies for the modulation of immune responses
WO2004055050A2 (en) * 2002-12-10 2004-07-01 Endocube Sas Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
JP2007020401A (ja) * 2003-10-23 2007-02-01 Univ Kurume 可溶型インターフェロンγ受容体遺伝子導入法
EP1846033A4 (en) * 2005-01-04 2009-09-23 Univ Rochester BLOCKADE OF ELR + CXC CHEMOKINES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
MX2010001307A (es) * 2007-08-02 2010-07-30 Novimmune Sa Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos.
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer
US20140130373A1 (en) 2012-11-15 2014-05-15 Nike, Inc. Article Of Footwear Incorporating A Knitted Component

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464938A (en) * 1990-04-09 1995-11-07 Immunex Corporation Isolated viral protein TNF antagonists
ATE112312T1 (de) * 1990-04-24 1994-10-15 Schering Corp Lösliche verkürzte interferon-gamma rezeptoren.

Also Published As

Publication number Publication date
JP2007332145A (ja) 2007-12-27
PT840615E (pt) 2003-10-31
DE69628838T2 (de) 2004-05-06
WO1996033730A2 (en) 1996-10-31
US5834419A (en) 1998-11-10
AU6237996A (en) 1996-11-18
JPH11504036A (ja) 1999-04-06
ATE243526T1 (de) 2003-07-15
WO1996033730A3 (en) 1996-12-12
EP0840615A2 (en) 1998-05-13
CA2218499A1 (en) 1996-10-31
ES2202452T3 (es) 2004-04-01
DE69628838D1 (de) 2003-07-31
CA2218499C (en) 2007-02-20
EP0840615B1 (en) 2003-06-25
AU718049B2 (en) 2000-04-06
JP4077876B2 (ja) 2008-04-23

Similar Documents

Publication Publication Date Title
DK0840615T3 (da) Kemokin-bindende protein og fremgangsmåder til anvendelse deraf
DK1482042T3 (da) Aktive og inaktive CC-kemokinreceptorer og nukleinsyremolekyler der koder for receptoren
UA42760C2 (uk) Спосіб спрямування клітинної імунної відповіді проти віл-інфікованої клітини ссавця,білковий мембранозв'язаний химерний рецептор,днк,яка кодує химерний рецептор,вектор,що її містить
DK317288D0 (da) Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det
DK1017715T3 (da) Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse
NO985412D0 (no) Type-2 kjemokinbindende proteiner og anvendelser derav
DE69933696D1 (de) Cytokinrezeptor-kette
CY1110381T1 (el) Πεπτιδια χ-κωνοτοξινης ως αναστολεις των νευρωνικων αμινικων μεταφορεων
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
DE60025704D1 (de) Das goodpasture-antigen bindende protein
DE69128039T2 (de) Allergene aus roggenspreupollen
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
PE20399A1 (es) Muteina ob
ATE391137T1 (de) G-protein gekoppelter rezeptor
DK270386D0 (da) Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse
ATE307201T1 (de) Srcr domäne-enthaltendes protein
DK43393D0 (da) Dna-sekvens, der koder for et enzym
NO920500L (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav
DK532885D0 (da) Klemme til brug fx som toejklemme og legetoejsbyggesaet, i hvilket klemmen indgaar